We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Association of bisphosphonate with bone loss and pain-related behaviour in an adjuvant-induced osteoporosis model.
- Authors
Norihiro Mayumi; Hiroki Wakabayashi; Gaku Miyamura; Akihiro Sudo
- Abstract
Objectives: Osteoporosis animal models are used extensively to determine the mechanisms of disease pathology and identify potential biological targets. The study aimed to establish a bone loss model, identify pain-related behaviour in neighbouring joints using an adjuvant-induced osteoporosis model, and examine the therapeutic effect of bisphosphonates. Methods: Complete Freund's adjuvant was injected subcutaneously into the back of the right foot of 8-week-old female ddY mice. Subsequently, pain, arthritis, and bone density in the right knee were monitored over time. Results: Pain evaluation using von Frey filaments showed a significantly exacerbated knee pain threshold compared to the control group (saline administration) at 7- and 14-day intervals after complete Freund's adjuvant administration, and bone density during the same period also significantly declined. The adjuvant-induced osteoporosis model was created similarly; alendronate 40 μg/kg was subcutaneously injected twice and vehicle once from 7 to 14 days after onset. In the alendronate administration group on the 14th day, significant improvements in bone density, arthritis, and pain threshold around the knee were observed compared to the untreated group. Conclusions: Alendronate may contribute to pain improvement through the simultaneous effects of bone mass improvement and suppression of osteoporotic pain.
- Subjects
PATHOLOGY; PAIN threshold; BONE density; DRUG target; KNEE pain
- Publication
Modern Rheumatology, 2024, Vol 34, Issue 4, p841
- ISSN
1439-7595
- Publication type
Article
- DOI
10.1093/mr/road085